Purpura, Thrombocytopenic, Idiopathic
"Purpura, Thrombocytopenic, Idiopathic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
MeSH Number(s)
C15.378.100.802.687.600
C15.378.140.855.925.750.600
C15.378.463.740
C20.111.759
C20.841.600
C23.550.414.950.687.600
C23.888.885.687.687.600
Concept/Terms
Purpura, Thrombocytopenic, Idiopathic- Purpura, Thrombocytopenic, Idiopathic
- Werlhof's Disease
- Disease, Werlhof's
- Werlhofs Disease
- Purpura, Thrombocytopenic, Autoimmune
- Werlhof Disease
- Disease, Werlhof
- Autoimmune Thrombocytopenic Purpura
- Autoimmune Thrombocytopenic Purpuras
- Purpura, Autoimmune Thrombocytopenic
- Purpuras, Autoimmune Thrombocytopenic
- Thrombocytopenic Purpura, Autoimmune
- Thrombocytopenic Purpuras, Autoimmune
- Idiopathic Thrombocytopenic Purpura
- Idiopathic Thrombocytopenic Purpuras
- Purpura, Idiopathic Thrombocytopenic
- Purpuras, Idiopathic Thrombocytopenic
- Thrombocytopenic Purpura, Idiopathic
- Thrombocytopenic Purpuras, Idiopathic
Autoimmune Thrombocytopenia- Autoimmune Thrombocytopenia
- Autoimmune Thrombocytopenias
- Thrombocytopenia, Autoimmune
- Thrombocytopenias, Autoimmune
Below are MeSH descriptors whose meaning is more general than "Purpura, Thrombocytopenic, Idiopathic".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Blood Coagulation Disorders [C15.378.100]
- Purpura [C15.378.100.802]
- Purpura, Thrombocytopenic [C15.378.100.802.687]
- Purpura, Thrombocytopenic, Idiopathic [C15.378.100.802.687.600]
- Blood Platelet Disorders [C15.378.140]
- Thrombocytopenia [C15.378.140.855]
- Thrombotic Microangiopathies [C15.378.140.855.925]
- Purpura, Thrombocytopenic [C15.378.140.855.925.750]
- Purpura, Thrombocytopenic, Idiopathic [C15.378.140.855.925.750.600]
- Hemorrhagic Disorders [C15.378.463]
- Purpura, Thrombocytopenic, Idiopathic [C15.378.463.740]
- Immune System Diseases [C20]
- Autoimmune Diseases [C20.111]
- Purpura, Thrombocytopenic, Idiopathic [C20.111.759]
- Purpura, Thrombocytopenic [C20.841]
- Purpura, Thrombocytopenic, Idiopathic [C20.841.600]
- Pathological Conditions, Signs and Symptoms [C23]
- Pathologic Processes [C23.550]
- Hemorrhage [C23.550.414]
- Purpura [C23.550.414.950]
- Purpura, Thrombocytopenic [C23.550.414.950.687]
- Purpura, Thrombocytopenic, Idiopathic [C23.550.414.950.687.600]
- Signs and Symptoms [C23.888]
- Skin Manifestations [C23.888.885]
- Purpura [C23.888.885.687]
- Purpura, Thrombocytopenic [C23.888.885.687.687]
- Purpura, Thrombocytopenic, Idiopathic [C23.888.885.687.687.600]
Below are MeSH descriptors whose meaning is more specific than "Purpura, Thrombocytopenic, Idiopathic".
This graph shows the total number of publications written about "Purpura, Thrombocytopenic, Idiopathic" by people in Harvard Catalyst Profiles by year, and whether "Purpura, Thrombocytopenic, Idiopathic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
1997 | 1 | 0 | 1 |
2000 | 1 | 1 | 2 |
2001 | 3 | 0 | 3 |
2002 | 2 | 1 | 3 |
2003 | 3 | 1 | 4 |
2004 | 1 | 0 | 1 |
2005 | 3 | 0 | 3 |
2006 | 2 | 0 | 2 |
2007 | 1 | 2 | 3 |
2008 | 6 | 2 | 8 |
2009 | 6 | 0 | 6 |
2010 | 7 | 0 | 7 |
2011 | 5 | 0 | 5 |
2012 | 3 | 0 | 3 |
2013 | 5 | 2 | 7 |
2014 | 3 | 1 | 4 |
2015 | 6 | 1 | 7 |
2016 | 6 | 0 | 6 |
2017 | 4 | 0 | 4 |
2018 | 12 | 0 | 12 |
2019 | 14 | 0 | 14 |
2020 | 9 | 0 | 9 |
2021 | 18 | 1 | 19 |
2022 | 20 | 0 | 20 |
2023 | 10 | 0 | 10 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Purpura, Thrombocytopenic, Idiopathic" by people in Profiles.
-
How I treat thrombocytopenia in pregnancy. Blood. 2024 Feb 29; 143(9):747-756.
-
How to manage ITP with life-threatening bleeding. Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):254-258.
-
Avatrombopag for adults with early versus chronic immune thrombocytopenia. Am J Hematol. 2024 Feb; 99(2):155-162.
-
Novel therapeutics and future directions for refractory immune thrombocytopenia. Br J Haematol. 2023 10; 203(1):65-78.
-
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2023 11 04; 402(10413):1648-1659.
-
New insights into the glycobiology of immune thrombocytopenia. Curr Opin Hematol. 2023 11 01; 30(6):210-218.
-
Common-sense combination therapy in refractory immune thrombocytopaenia. Br J Haematol. 2023 08; 202(4):728-730.
-
A New Patient with p40phox Deficiency and Chronic Immune Thrombocytopenia. J Clin Immunol. 2023 08; 43(6):1173-1177.
-
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert Rev Hematol. 2023 05; 16(5):365-375.
-
ITP definitions: Time for an update. Br J Haematol. 2023 06; 201(5):1005-1006.